CAPTRUST Financial Advisors
VYGR icon

CAPTRUST Financial Advisors’s Voyager Therapeutics VYGR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Buy
111,987
+7,133
+7% +$27.1K ﹤0.01% 2362
2026
Q1 		$405K Buy
104,854
+1,205
+1% +$4.74K ﹤0.01% 2173
2025
Q4 		$407K Buy
103,649
+82
+0.1% +$363 ﹤0.01% 2029
2025
Q3 		$484K Sell
103,567
-400
-0.4% -$1.45K ﹤0.01% 1839
2025
Q2 		$323K Sell
103,967
-1,723
-2% -$5.56K ﹤0.01% 2004
2025
Q1 		$357K Sell
105,690
-23,069
-18% -$108K ﹤0.01% 1846
2024
Q4 		$730K Buy
128,759
+313
+0.2% +$2.02K ﹤0.01% 1406
2024
Q3 		$751K Sell
128,446
-495
-0.4% -$3.6K ﹤0.01% 1356
2024
Q2 		$1.02M Sell
128,941
-62
-0% -$520 ﹤0.01% 1124
2024
Q1 		$1.2M Buy
129,003
+103,852
+413% +$877K ﹤0.01% 1027
2023
Q4 		$212K Buy
25,151
+3,151
+14% +$22.9K ﹤0.01% 2356
2023
Q3 		$171K Hold
22,000
– – ﹤0.01% 2333
2023
Q2 		$252K Buy
+22,000
New +$228K ﹤0.01% 2105

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CAPTRUST Financial Advisors's VYGR Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Voyager Therapeutics (VYGR) stake by 6.8% in Q2 2026, buying an estimated $27.1K and bringing the position to 111,987 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #2362.

CAPTRUST Financial Advisors first reported a position in VYGR in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.2M in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • CAPTRUST Financial Advisors held 111,987 shares of Voyager Therapeutics worth $392K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 7,133 Voyager Therapeutics shares in Q2 2026, an estimated $27.1K.
  • Voyager Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2362 holding.
  • CAPTRUST Financial Advisors first reported a position in Voyager Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • CAPTRUST Financial Advisors's Voyager Therapeutics position peaked at $1.2M in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.